Milestone Scientific Inc. (MLSS) Stock Performance Update
Milestone Scientific Inc. (ticker MLSS) closed the trading day on Friday, 23 March 2026, at a price of USD 0.31. The share price fell 8.82 % during the 24‑hour period ending at 12:58 AM Central Europe time.
Market Metrics
- Current trading price: USD 0.31
- Total shares outstanding: 88.7 million
- Market capitalization: USD 30 million
- 24‑hour trading volume: approximately USD 40,000 worth of shares
- Year‑to‑date change: -22.5 % since the end of February
- 200‑day simple moving average: USD 0.35
- 52‑week high: USD 0.58 (13 August 2026)
- 52‑week low: USD 0.22 (22 January 2026)
The decline in price is the most significant within the past month, reflecting a broader downward trend in the company’s valuation. The current trading volume is modest compared to the company’s overall market capitalization, indicating limited liquidity at present.
Comparison with Related Stocks
| Ticker | Recent % Move | Current Price (USD) | Market Cap (USD) |
|---|---|---|---|
| OLNCF (Omni‑lite Industries Canada) | -0.45 % | 2.28 | 35.3 million |
| WAMFF (Alaska Silver) | +9.12 % | 0.33 | 35.4 million |
| CELU (Celularity) | -19.05 % | 1.05 | 35.7 million |
| CRVO (Cervomed) | +2.18 % | 2.24 | 35.4 million |
Milestone Scientific’s performance contrasts sharply with the modest gains seen in Alaska Silver and Cervomed, while it aligns more closely with the decline experienced by Celularity. The company’s price movement is more pronounced than the slight decline of Omni‑lite Industries Canada.
Company Overview
Milestone Scientific Inc. is a medical‑technology firm that develops, manufactures, markets, and sells computer‑controlled local anesthetic delivery systems. The products are intended for use in plastic surgery, podiatry, dermatology, and orthopedics. The company operates on a global basis and serves the broader medical sector.
- Website: www.milestonescientific.com
- Exchange listing: NYSE MKT
- IPO date: 3 November 1995
The company’s core competency lies in precision anesthetic delivery, a niche segment within the broader medical device market. Its revenue streams are primarily driven by sales of proprietary anesthetic delivery systems and associated consumables.
Investor Considerations
- Liquidity: With an average daily volume of roughly USD 40,000 against a market cap of USD 30 million, trading liquidity is limited.
- Volatility: The share price has experienced a 22.5 % decline month‑to‑date, indicating heightened volatility.
- Valuation: The current price is below the 200‑day simple moving average (USD 0.35), suggesting a potential oversold condition.
- Sector Context: The medical‑device sector remains subject to regulatory scrutiny and patent lifecycle considerations, which may influence future performance.
Investors should weigh these factors in the context of their risk tolerance and investment horizon.